Reference terms from Wikipedia, the free encyclopedia
 

Coeliac disease

Coeliac disease or celiac disease is a long-term autoimmune disorder that primarily affects the small intestine. Classic symptoms include gastrointestinal problems such as chronic diarrhoea, abdominal distention, malabsorption, loss of appetite, and among children failure to grow normally. This often begins between six months and two years of age. Non-classic symptoms are more common, especially in people older than two years. There may be mild or absent gastrointestinal symptoms, a wide number of symptoms involving any part of the body, or no obvious symptoms. Coeliac disease was first described in childhood; however, it may develop at any age. It is associated with other autoimmune diseases, such as Type 1 diabetes mellitus and Hashimoto's thyroiditis, among others.

Coeliac disease is caused by a reaction to gluten, a group of various proteins found in wheat and in other grains such as barley and rye. Moderate quantities of oats, free of contamination with other gluten-containing grains, are usually tolerated. The occurrence of problems may depend on the variety of oat. It occurs in people who are genetically predisposed. Upon exposure to gluten, an abnormal immune response may lead to the production of several different autoantibodies that can affect a number of different organs. In the small bowel, this causes an inflammatory reaction and may produce shortening of the villi lining the small intestine (villous atrophy). This affects the absorption of nutrients, frequently leading to anaemia.

Diagnosis is typically made by a combination of blood antibody tests and intestinal biopsies, helped by specific genetic testing. Making the diagnosis is not always straightforward. About 10% of the time, the autoantibodies in the blood are negative, and many people have only minor intestinal changes with normal villi. People may have severe symptoms and they may be investigated for years before a diagnosis is achieved. Increasingly, the diagnosis is being made in people without symptoms, as a result of screening. Evidence regarding the effects of screening, however, is not sufficient to determine its usefulness. While the disease is caused by a permanent intolerance to gluten proteins, it is distinct from wheat allergy, which is much more rare.

The only known effective treatment is a strict lifelong gluten-free diet, which leads to recovery of the intestinal mucosa, improves symptoms, and reduces the risk of developing complications in most people. If untreated, it may result in cancers such as intestinal lymphoma, and a slightly increased risk of early death. Rates vary between different regions of the world, from as few as 1 in 300 to as many as 1 in 40, with an average of between 1 in 100 and 1 in 170 people. It is estimated that 80% of cases remain undiagnosed, usually because of minimal or absent gastrointestinal complaints and lack of knowledge of symptoms and diagnostic criteria. Coeliac disease is slightly more common in women than in men.

 
Note:   The above text is excerpted from the Wikipedia article Coeliac disease, which has been released under the GNU Free Documentation License.
 

Check out these latest Nanowerk News:

 

Researchers develop a new predictive model for designing 2D perovskites

By separating dielectric-screening effects from structural distortion, the study offers practical design rules for tuning excitons in 2D perovskites.

Orbitronics breakthrough points to low-power memory

Researchers directly used orbital currents in a magnetic device, producing much stronger signals for future low-energy memory and processors.

Microscopy at the space-time limit

Ultrafast scanning tunneling microscopy reaches the quantum mechanical space-time limit for the first time.

Programmable molecular machines are getting closer

Researchers created a highly stable electrically controlled DNA origami switch that regulates molecular functions and keeps working through hundreds of thousands of cycles.

Nanozyme tags reveal where nanoparticles go in cells

A new nanozyme labeling method maps nanoparticle interactions in living cells, showing how targeting alters trafficking and could guide better nanomedicines.

Light-written magnetic memory moves closer

Researchers used laser pulses to write and read antiferromagnetic data, opening a path to faster, lower-energy memory linked to optical networks.

Laser-controlled molecules reveal hidden reaction dynamics

Synchronized infrared lasers steer molecules between structures, exposing clear spectral fingerprints and new ways to study chemical reactions.

MOF thin films reveal a denser, less porous structure than expected

Advanced diffraction and modeling show a widely studied MOF thin film is densely packed, reshaping expectations for sensors, microelectronics and magnetic storage.

Atomic-scale insights clarify hidden defect signals in carbon materials

New analysis links long-ambiguous carbon defect peaks to specific atomic structures, helping improve material design for energy and electronics.

Room-temperature photon source brings quantum security closer to deployment

A compact plug-and-play device produces single photons without cryogenic cooling, easing integration with quantum-secure communication networks.